Bilirubin, direct

Elevated direct bilirubin specifically indicates problems with bile flow or excretion, such as bile duct obstruction (gallstones, tumors), intrahepatic cholestasis, or hepatocellular injury (hepatitis, cirrhosis). Unlike indirect bilirubin, high direct bilirubin can appear in urine, causing dark coloration. Early detection enables intervention for potentially reversible causes like medication effects or gallstones before permanent liver damage occurs.

Most adults benefit from yearly direct bilirubin testing alongside total bilirubin, as part of a comprehensive liver panel. When elevated, your clinician guides the follow-up.

At baseline / for screening: Once every 12 months from age 30 as part of a comprehensive panel. More frequently, every 3 to 6 months, if you have known liver disease, regular alcohol intake, fatty liver (MASLD), or take hepatotoxic medication.

When monitoring an intervention or change: Mild isolated elevations, particularly indirect bilirubin in Gilbert's syndrome, don't need a specific retest cadence. When bilirubin is elevated alongside abnormal liver enzymes or other symptoms, your clinician guides the workup rather than a fixed bilirubin retest interval.

Note: If elevated, retest at 4 to 6 weeks alongside the broader liver panel to confirm the trend.